Suppr超能文献

皮肤科中的碘化钾——作用机制、制剂、用途及不良反应的最新进展

Potassium Iodide in Dermatology- Recent Advances in Mechanism of Action, Preparation, Uses and Adverse Effects.

作者信息

Goel Nishant, Doshi Bhavana R

机构信息

From the Department of Dermatology, Venereology and Leprosy, J. N. Medical College, Belagavi, Karnataka, India.

出版信息

Indian J Dermatol. 2025 May-Jun;70(3):169. doi: 10.4103/ijd.ijd_508_24. Epub 2025 May 8.

Abstract

Potassium iodide (KI) is a simple yet versatile drug. It has been successfully used for the treatment of various diseases in dermatology, but there are very limited studies on the exact mechanism of action, preparation, and dosage of potassium iodide, causing concerns regarding its toxicity. This article reviews the multimodal mechanism of action of KI and standardises the method of preparation of a saturated solution of potassium iodide (SSKI) on an OPD basis. It also lists the existing and newer indications, optimal dosages, adverse effects, and contraindications of potassium iodide, thereby enabling the proper utilisation of this age-old remedy as a cost-effective yet safe treatment option for various inflammatory dermatoses, including panniculitis (erythema nodosum, erythema induratum, subacute nodular migratory panniculitis), Wegener's granulomatosis, granuloma annulare, Behcet's syndrome, pyoderma gangrenosum, Sweet's syndrome, and erythema multiforme. Potassium iodide is also used for fungal infections, including cutaneous and lymphocutaneous sporotrichosis, cutaneous cryptococcosis, entomophthoramycosis, human pythiosis, chromoblastomycosis, and mucormycosis.

摘要

碘化钾(KI)是一种简单却用途广泛的药物。它已成功用于皮肤科多种疾病的治疗,但关于碘化钾的确切作用机制、制剂和剂量的研究非常有限,这引发了人们对其毒性的担忧。本文综述了碘化钾的多模式作用机制,并在门诊基础上规范了碘化钾饱和溶液(SSKI)的制备方法。文章还列出了碘化钾现有的和新的适应证、最佳剂量、不良反应及禁忌证,从而能够合理利用这种古老的药物,将其作为一种经济高效且安全的治疗选择,用于治疗各种炎症性皮肤病,包括脂膜炎(结节性红斑、硬结性红斑、亚急性结节性游走性脂膜炎)、韦格纳肉芽肿、环状肉芽肿、白塞病、坏疽性脓皮病、Sweet综合征和多形红斑。碘化钾还用于真菌感染,包括皮肤和淋巴管型孢子丝菌病、皮肤隐球菌病、虫霉病、人类腐皮病、着色芽生菌病和毛霉病。

相似文献

1
Potassium Iodide in Dermatology- Recent Advances in Mechanism of Action, Preparation, Uses and Adverse Effects.
Indian J Dermatol. 2025 May-Jun;70(3):169. doi: 10.4103/ijd.ijd_508_24. Epub 2025 May 8.
3
Potassium iodide in erythema nodosum and other erythematous dermatoses.
J Am Acad Dermatol. 1983 Jul;9(1):77-81. doi: 10.1016/s0190-9622(83)70110-6.
4
Exploring the combination of SSKI and topical heparin in a case of erythema nodosum migrans.
Dermatol Ther. 2018 Jul;31(4):e12610. doi: 10.1111/dth.12610. Epub 2018 Apr 11.
5
Cutaneous sporotrichosis treatment with potassium iodide: a 24 year experience in São Paulo State, Brazil.
Rev Inst Med Trop Sao Paulo. 2011 Mar-Apr;53(2):89-93. doi: 10.1590/s0036-46652011000200006.
6
Potassium Iodide for Cutaneous Inflammatory Disorders: A Monocentric, Retrospective Study.
Dermatology. 2019;235(2):137-143. doi: 10.1159/000494614. Epub 2018 Nov 21.
7
Potassium iodide remains the most effective therapy for cutaneous sporotrichosis.
J Dermatolog Treat. 2003 Dec;14(4):200-2. doi: 10.1080/09546630310020452.
9
Neutrophilic Dermatosis of the Hands: A Case Report.
Acta Dermatovenerol Croat. 2023 Dec;31(3):148-50.
10
Oral potassium iodide for the treatment of sporotrichosis.
Mycopathologia. 2009 Jun;167(6):355-6. doi: 10.1007/s11046-008-9178-0. Epub 2009 Jan 8.

本文引用的文献

1
Toxic Epidermal Necrolysis Secondary to Iodine Versus Methimazole in a Pediatric Patient With Complex Autoimmune Disease.
Cureus. 2024 Apr 4;16(4):e57618. doi: 10.7759/cureus.57618. eCollection 2024 Apr.
2
Elevated levels of iodide promote peroxidase-mediated protein iodination and inhibit protein chlorination.
Free Radic Biol Med. 2024 Aug 1;220:207-221. doi: 10.1016/j.freeradbiomed.2024.04.230. Epub 2024 Apr 23.
3
Subcutaneous zygomycosis in an immunocompetent patient caused by .
BMJ Case Rep. 2023 Jan 5;16(1):e253515. doi: 10.1136/bcr-2022-253515.
4
Subcutaneous entomophthoromycosis in an immunocompetent individual: a localised forearm swelling.
BMJ Case Rep. 2022 Dec 1;15(12):e247395. doi: 10.1136/bcr-2021-247395.
6
7
Dermatitis Herpetiformis: An Update on Diagnosis and Management.
Am J Clin Dermatol. 2021 May;22(3):329-338. doi: 10.1007/s40257-020-00584-2.
8
Clinical Studies on Potassium Iodide-induced Painless Thyroiditis in 11 Graves' Disease Patients.
Intern Med. 2021 Jun 1;60(11):1675-1680. doi: 10.2169/internalmedicine.6411-20. Epub 2021 Jan 8.
10
Clinical Management of Hyperkalemia.
Mayo Clin Proc. 2021 Mar;96(3):744-762. doi: 10.1016/j.mayocp.2020.06.014. Epub 2020 Nov 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验